Highly specific, NIR fluorescent contrast agent with emission controlled by gold nanoparticle.

Area of Science:

• Biomedical Engineering
• Nanotechnology
• Molecular Imaging

Background:

• Nanoparticles offer unique properties for in vivo molecular imaging.
• Metal nanoparticles can alter fluorescence via surface plasmon fields.
• Developing targeted contrast agents is crucial for early disease detection.

Purpose of the Study:

• To develop a nanosized, near-infrared (NIR) fluorophore-based contrast agent for breast cancer diagnosis.
• To utilize the fluorescence-quenching and restoration mechanism for targeted cancer cell detection.
• To achieve dual specificity through cancer cell targeting and enzyme-cleavable linkers.

Main Methods:

• Conjugating an NIR fluorophore to gold nanoparticles (GNP) using a specifically designed short spacer.
• Adjusting the spacer length to enable fluorescence quenching by the GNP's surface plasmon field.
• Incorporating a cancer-targeting molecule and an enzyme-cleavable sequence within the spacer.

Main Results:

• The developed entity remains non-fluorescent until delivered to the cancer site.
• Enzymatic cleavage of the spacer by cancer-specific enzymes restores fluorescence.
• The agent demonstrates dual specificity, targeting cancer cells and responding to specific cancer biomarkers.

Conclusions:

• This GNP-based nanosystem offers a promising approach for highly specific breast cancer diagnosis.
• The fluorescence restoration mechanism provides a sensitive indicator for cancer presence.
• Future applications include combining this diagnostic agent with therapeutic drugs for personalized cancer treatment.